At a Glance: Canadian Institutes of Health Research (CIHR) Departmental Evaluation Plan 2024-25 to 2028-29
- Under the Policy on Results, CIHR's President is responsible for annually approving and providing to the Treasury Board of Canada Secretariat a five-year, rolling Departmental Evaluation Plan (DEP).
- CIHR's Evaluation Unit (EU) develops the DEP, in accordance with the Policy on Results, as part of its annual evaluation planning in consultation with CIHR's Performance Measurement and Evaluation Committee (PMEC), Program Officials, and the Treasury Board of Canada Secretariat.
- The 2024-25 DEP outlines the work of the Evaluation Unit for the five-year period from 2024-25 to 2028-29 to meet evaluation coverage of program spending, support the President to make evidence-based decisions, and demonstrate accountability for results achieved by CIHR.
- The DEP was recommended for approval by CIHR's Performance Measurement and Evaluation Committee, approved by CIHR's President and submitted to the Results Division of the Treasury Board of Canada Secretariat in June 2024.
- Table 1 presents the key achievements from fiscal year 2023-24 and the planned and ongoing for evaluation activities for 2024-25; Table 2 outlines the planned evaluation coverage for five-year period of the 2024-25 DEP.
Table 1: 2023-24 Achievements and 2024-25 Activities
| 2023-24 DEP Achievements | Projects (Lead) |
|---|---|
| Completed | 1. Evaluation of the Strategy for Patient-Oriented Research (CIHR) |
| 2. Evaluation of CIHR's Operating Support Program (CIHR) | |
| 3. Evaluation Framework for the Centre for Research on Pandemic Preparedness and Health Emergencies (CIHR) | |
| 4. The Talent Evaluation: An Evaluation of the Tri-Agencies' Support for Research Training and Talent Development (NSERC) | |
| 5. Horizontal Evaluation of the Canadian Drug and Safety Strategy (Health Canada) | |
| 6. Independent Evaluation of the Canada Gairdner Awards (The Evidence Network and Gairdner Foundation) |
| 2024-25 DEP Activities | Projects (Lead) |
|---|---|
| Ongoing | 1. Evaluation of the Banting Postdoctoral Fellowships Program (CIHR) |
| 2. Evaluation of the Antimicrobial Resistance Research Initiative (CIHR) | |
| 3. Evaluation of CIHR's HIV/AIDS and STBBI Research Initiative (CIHR) | |
| 4. Assessment of CIHR's COVID-19 Research Investments (CIHR) | |
| 5. Evaluation of the Clinical Trials Fund (CIHR) | |
| 6. Evaluation of the New Frontiers in Research Fund (SSHRC) | |
| 7. Evaluation of the Canadian Excellence Research Chairs (SSHRC) | |
| 8. Canada First Research Excellence Fund Evaluation (SSHRC) | |
| 9. Evaluation of the College and Community Innovation Program (NSERC) | |
| Planned | 10. Evaluation of the Network Environments for Indigenous Health Research Program (CIHR) |
| 11. Evaluation of the Vanier Canada Graduate Scholarships (CIHR) | |
| 12. Evaluation of the Centre for Research on Pandemic Preparedness and Health Emergencies (CIHR) |
Table 2. Evaluation Coverage of Program Spending 2024-25 to 2028-29
| Program (2024-25 Program Spending)Footnote 1 | Planned and Ongoing Evaluations for the next 5 years | Fiscal Year of Approval | 2024–25 Evaluation Coverage | 2024-25 Program CoverageFootnote 3 |
|---|---|---|---|---|
|
Investigator-Initiated Research: $870,843,213 G&A: $832,405,352 Operating: $38,437,861 |
1. Canadian Excellence Research Chairs (CERC) | 2025-26 | $13,609,779 | $864,773,101 (99.3%) |
| 2. Canada First Research Excellence Fund (CFREF) Evaluation | 2025-26 | $60,504,963 | ||
| 3. Canada Research Chairs Program (CRCP) Evaluation | 2027-28 | $125,269,324 | ||
| 4. Evaluation of Project Grant Program (PGP) Evaluation | 2028-29 | $665,389,034 | ||
|
Training and Career Support: $80,976,604 G&A: $73,267,587 Operating: $7,709,017 |
5. Evaluation of the Banting Postdoctoral Fellowships Program | 2024-25 | $3,610,376 | $80,976,604 (100%) |
| 6. Evaluation of the Vanier Canada Graduate Scholarships ProgramFootnote 2 | 2025-26 | $9,228,564 | ||
| 7. Evaluation of CIHR Training and Career Support (TCS) ProgramFootnote 2 | 2027-28 | $21,887,083 | ||
| 8. Canada Graduate Scholarships (CGS) ProgramFootnote 2 | 2027-28 | $46,250,581 | ||
|
Research in Priority Areas: $417,741,236 G&A: $378,927,421 Operating: $38,813,482 |
9. Evaluation of the Antimicrobial Resistance Research Initiative (AMRI) | 2024-25 | $1,991,369 | $382,326,469 (91.5%) |
| 10. Evaluation of the CIHR HIV/AIDS and STBBI Research Initiative | 2024-25 | $23,945,665 | ||
| 11. Evaluation of the College and Community Innovation (CCI) Program | 2024-25 | $2,247,420 | ||
| 12. Evaluation of the Clinical Trials Fund | 2024-25 | $77,033,170 | ||
| 13. Evaluation of the Network Environments for Indigenous Health Research (NEIHR) Program | 2025-26 | $2,765,791 | ||
| 14. Evaluation of Centre for Research on Pandemic Preparedness and Health EmergenciesFootnote 3 | 2025-26 | $20,051,500 | ||
| 15. Review of Climate Change Health Research Initiative | 2025-26 | $1,372,725 | ||
| 16. Evaluation of the CIHR Institutes | 2027-28 | $161,094,277 | ||
| 17. Evaluation of the Canadian Longitudinal Study on Aging (CLSA) | 2026-27 | $9,624,951 | ||
| 18. Evaluation of the Brain Health and Cognitive Impairment in Aging Initiative including CCNA | 2026-27 | $10,168,890 | ||
| 19. Evaluation of the Strategy for Patient-Oriented Research (SPOR) | 2028-29 | $65,767,867 | ||
| 20. Evaluation of the Canadian Drugs and Substances (CDSS) Strategy | 2028-29 | $5,663,575 | ||
| 21. Evaluation of the Gairdner FoundationFootnote 2 | 2023-24 | $719,106 | ||
|
Internal Services: Internal Services are allocated to the Operating Budget for each Program/Initiative (see above) |
22. Strategic Plan Implementation Review | 2026-27 | N/A | N/A |
|
Total Budget: $1,369,560,721 |
$1,328,076,173 | $1,328,076,173 (97.0%) |
- Date modified: